caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1275640179

Atis BarzdinsM.D.

PRACTICEPACMED CLINICSSee all providers at this practice →
Hematology-OncologySeattle, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 500014
Hospital
CCN 500026
Hospital
CCN 500027
Hospital
CCN 500088
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
405
Unique beneficiaries
—
Total services
861
Distinct HCPCS
11
Medicare payment
$51K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 247 Hematology-Oncology providers in WA — top quintile (cohort median 770).
REFERRAL NETWORK

Where Atis Barzdins's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Seattle, WA
841,508
Sharmila Ahmed
Hematology · Seattle, WA
25215
SWEDISH HEALTH SERVICES17120
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Seattle, WA
621,110
Vikramsinh Dabhi
Hematology-Oncology · Seattle, WA
26651
Sharmila Ahmed
Hematology · Seattle, WA
24299
SWEDISH HEALTH SERVICES2194
LABORATORY CORPORATION OF AMERICA17247
VIRGINIA MASON MEDICAL CENTER13142
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
482
Beneficiaries
—
Total drug cost
$407K
Distinct drugs
14
Brand share
35.9%
Top prescribed drugs
Rivaroxaban87 claims
Apixaban63 claims
Anastrozole57 claims
Prednisone48 claims
Tamoxifen Citrate37 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.